(Q40173738)

18 September 2017

Interleukin 21 therapy increases the density of tumor infiltrating CD8+ T cells and inhibits the growth of syngeneic tumors (English)

1 reference

18 September 2017

Henrik Søndergaard

1

1 reference

18 September 2017

Klaus S Frederiksen

2

1 reference

18 September 2017

Peter Thygesen

3

1 reference

18 September 2017

Elisabeth D Galsgaard

4

1 reference

18 September 2017

Kresten Skak

5

1 reference

18 September 2017

Paul E G Kristjansen

6

1 reference

18 September 2017

Niels Odum

7

1 reference

18 September 2017

Michael Kragh

8

1 reference

18 September 2017

7 February 2007

1 reference

Cancer Immunology, Immunotherapy

18 September 2017

1 reference

18 September 2017

56

1 reference

18 September 2017

9

1 reference

18 September 2017

1417-1428

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-007-0285-4

18 September 2017

0 references

cites work

IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 induces the functional maturation of murine NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

The immunization site of cytokine-secreting tumor cell vaccines influences the trafficking of tumor-specific T lymphocytes and antitumor efficacy against regional tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 induces tumor rejection by specific CTL and IFN-gamma-dependent CXC chemokines in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 influences the frequency, phenotype, and affinity of the antigen-specific CD8 T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

Interleukin-21 enhances NK cell activation in response to antibody-coated targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

IL-21 enhances tumor rejection through a NKG2D-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-007-0285-4

10.1007/S00262-007-0285-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference